|
Take heed to this text  |
The Misso robotic will assist surgeons with personalised pre-planning and exact reducing for joint alternative. | Supply: Meril
Meril Life Sciences Pvt. Ltd. this week unveiled its Misso surgical robotic for simplifying orthopedic procedures.
The India-based firm introduced on LinkedIn that it’s growing surgical robotic for whole knee procedures. It mentioned it designed Misso to assist surgeons with personalised pre-planning and exact reducing for joint replacements.
Misso has an optical monitoring sensor, a six-axis articulated robotic arm, and “superior” security methods, claimed Meril. The surgical robotic can assist physicians carry out real-time hole checks and modify a surgical plan intraoperatively, it defined.
Varied reducing choices can be found on the Misso, together with full and partial reducing based mostly on surgeon choice. Chopping guides usually are not required, and the system can carry out a tibial reduce and a completely completed femur with all of the cuts, together with peg holes, in line with the firm.
Misso contains security options
Meril designed Misso with bone-movement monitoring to make sure security throughout procedures. If bone motion is noticed, the resection course of stops.
The resection will proceed with computerized restoration of the bone place. If the robotic system’s instruments contact the affected person or different object, the collaborative robotic arm will instantly cease shifting.
Misso makes use of optical tracking-based navigation and robotic help to make sure correct leads to shaping and aligning synthetic knee joint parts. The corporate goals to enhance post-operative outcomes, cut back problems, and promote sooner affected person restoration.
Meril joins aggressive surgical robotic market
Based in 2006, Meril mentioned it’s devoted to the innovation, design, and improvement of novel, clinically related gadgets. Its product portfolio contains vascular intervention gadgets, orthopedic implants, robotics, endo-surgery, ENT merchandise, and in-vitro diagnostics.
The corporate has joined the rising surgical robotics market, the place it is going to compete with orthopedic surgical robotic builders equivalent to Stryker and Zimmer Biomet. Stryker launched its its Mako surgical robotic in 2017 and launched a joint-replacement providing in February 2024.
Additionally in February, the U.S. Meals and Drug Administration (FDA) cleared Zimmer Biomet’s Rosa surgical robotic platform for shoulder and hip alternative procedures. The FDA had cleared it for partial knee alternative for partial knee alternative in April 2021.
Editor’s notice: This text is syndicated from The Robotic Report sibling web site MassDevice.